Here, we investigated the possible participation of GR in the crosstalk between endocrine and immune systems in CCC patients and analyzed whether some surrogate of GC sensitivity, i.e., GR expression, may be modified in CCC subjects known to present myocardial inflammation and hypertrophy. This evidence concerns the gene NR3C1 and hypertrophy.